Skip to main content
ICMR Says Biocon's Drug Trial Not Good Enough to Prove Mortality Reduction - The Wire 16-Jul-2020
ICMR Says Biocon's Drug Trial Not Good Enough to Prove Mortality Reduction - The Wire
Kiran Mazumdar Shaw and Balram Bhargava. Photos: Reuters and YouTube. Indian Council of Medical Research (ICMR) director-general Balram Bhargava has acknowledged that there is no evidence from clinical trials that the drugs Itolizumab and Tocilizumab, approve…
More...